Data protection Impressum

Life sciences

Researchers from HUG and UNIGE have developed patient-derived lung cancer “mini-tumors” to rapidly identify the most effective personalized treatments.

Geneva team develops lung cancer “mini-tumors” to accelerate personalized treatments

13 August 2025

Researchers at the University of Geneva have uncovered that astrocytes in the brain’s cortex originate from two distinct types of progenitors, a finding that could reshape therapeutic strategies for neurological disorders.

University of Geneva researchers uncover two distinct origins of key brain cells

11 August 2025

Two start-ups from Western Switzerland’s Health Valley, AzureCell Therapies and Myriad Optics, have each been awarded CHF 150,000 through the Gebert Rüf Stiftung’s Innobooster programme, which supports high-potential projects emerging from Swiss universities.

AzureCell Therapies and Myriad Optics awarded by Gebert Rüf Stiftung’s Innobooster programme

11 August 2025

Biopôle has evolved its Start Up Fund into a 24 month scheme combining non dilutive capital, investor training and growth support.

Biopôle launches enhanced Investment Programme to boost life sciences start‑ups

6 August 2025

Oculis expands its loan facility with BlackRock to CHF 100 million, extending its financial runway and supporting late-stage clinical trials.

Oculis secures up to CHF 100 million in expanded loan facility with BlackRock

5 August 2025

Geneva Business School launches Switzerland’s first MBA in Biotech Management, blending business strategy with biotech innovation.

Geneva Business School launches Switzerland’s first MBA in Biotech Management

4 August 2025

Bern-based medtech Compremium is testing its compressibility-based device in patients with thyroid nodules to improve diagnostic precision and reduce unnecessary surgeries.

Compremium launches human study for non-invasive thyroid cancer diagnostic

15 July 2025

Vaud-based medtech Comphya strengthens its clinical pipeline with fresh capital and prepares for pivotal trials in the United States.

Comphya raises CHF 7.5 million for its neurostimulation therapy to treat erectile dysfunction

14 July 2025

Geneva-based biotech Stalicla secures funding to advance precision medicine programs for autism and substance use disorders.

Addex Therapeutics leads CHF 2 million investment in Stalicla

14 July 2025

Biopôle adds 18 new private labs for life sciences scale-ups in Lausanne, offering flexible, plug-and-play infrastructure in the new Trypto building.

Biopôle expands with 18 new private laboratories for life sciences scale-ups

2 July 2025

1 2 3 4 5 … 43